report
describ
product
sever
mab
protein
major
immunodomain
sar
cov
nucleocapsid
protein
q
chong
k
develop
western
blot
assay
detect
antibodi
coronaviru
caus
sever
acut
respiratori
syndrom
clin
diagn
lab
immunol
one
repres
monoclon
antibodi
mab
select
character
react
specif
react
recombin
nativ
nucleocapsid
protein
sar
cov
reactiv
purifi
protein
util
mab
detector
antibodi
develop
antigen
captur
elisa
assess
littl
pg
purifi
n
protein
tcid
sar
cov
could
detect
antigen
captur
elisa
specif
bind
mab
purifi
sar
cov
nucleocapsid
antigen
effect
inhibit
human
sar
posit
serum
guinea
pig
serum
n
protein
recombin
baculovirusinfect
cell
could
also
identifi
n
protein
detect
ifa
igmposit
serum
sampl
collect
sar
confirm
patient
nine
sampl
collect
sar
recoveri
patient
fals
posit
result
given
sampl
healthi
individu
test
crossreact
occur
infecti
bronchiti
viru
ibv
chicken
coronaviru
test
monoclon
antibodybas
antigen
captur
elisa
thu
power
tool
earli
diagnosi
sar
cov
infect
sever
acut
respiratori
syndrom
coronaviru
sar
cov
caus
agent
new
emerg
diseas
worldwid
marra
et
al
diseas
wide
preval
countri
report
case
caus
death
thu
develop
diagnost
test
specif
earli
detect
sar
cov
contribut
risk
manag
diseas
present
sar
cov
infect
confirm
detect
viral
rna
via
pcr
rtpcr
drosten
et
al
poon
et
al
howev
technic
demand
techniqu
suscept
cross
contamin
determin
infecti
viru
sampl
carri
inocul
cell
cultur
vero
cell
patient
specimen
though
rel
time
consum
serolog
assay
develop
far
base
detect
specif
circul
antibodi
et
al
assay
highli
sensit
specif
detect
antibodi
sar
cov
howev
lack
detect
antibodi
sar
cov
infect
patient
earli
stage
throughout
whole
diseas
cours
report
case
see
front
matter
elsevi
bv
right
reserv
cur
sar
patient
immunocompromis
chronic
condit
eg
diabet
mellitu
chronic
renal
insuffici
may
remain
afebril
acut
ill
possess
symptom
attribut
underli
diseas
thu
delay
sar
diagnosi
houng
et
al
therefor
effort
direct
toward
develop
simpl
inexpens
assay
detect
sar
cov
protein
test
could
use
earli
detect
followup
patient
treatment
thu
reduc
workload
laboratori
personnel
antibodi
nucleocapsid
protein
longer
live
occur
greater
abund
sar
patient
antibodi
viral
compon
spike
membran
envelop
protein
chen
et
al
huang
et
al
kim
et
al
tan
et
al
timani
et
al
zhu
et
al
might
due
higher
express
nucleocapsid
compar
viral
protein
sar
cov
infect
rota
et
al
data
indic
nucleocapsid
could
play
crucial
role
antibodi
respons
infect
previou
work
major
immunodomain
recombin
sar
cov
nucleocapsid
identifi
use
develop
western
blot
detect
antibodi
sar
cov
infect
sensit
specif
respect
result
hypothes
monoclon
antibodi
would
specif
recogn
sar
cov
immunoassay
studi
produc
monoclon
antibodi
protein
monoclon
antibodi
character
sar
covinfect
vero
cell
nucleocapsidspik
fusion
proteinbas
ifa
western
blot
proteinbas
elisa
isotyp
promis
monoclon
antibodi
design
determin
appli
develop
specif
sensit
antigen
captur
elisa
detect
sar
cov
sensit
specif
antigen
captur
elisa
also
assess
rpmi
medium
fetal
bovin
serum
fb
obtain
invitrogen
carlsbad
ca
hypoxanthineaminopeterinthymidin
hat
supplement
use
propag
hybridoma
purchas
sigma
st
loui
mo
mice
myeloma
cell
spodoptera
frugiperda
cell
avail
laboratori
human
cell
vero
cell
obtain
institut
molecular
cell
biolog
imcb
singapor
inactiv
sar
cov
strain
provid
singapor
gener
hospit
twentyseven
sera
avail
patient
present
symptom
satisfi
world
health
organ
definit
sar
sera
obtain
healthi
individu
sera
provid
tock
seng
hospit
heat
inactiv
c
h
use
recombin
baculoviru
bear
fusion
gene
encod
sc
fragment
spike
protein
construct
describ
previous
et
al
commerci
sar
ifa
diagnost
kit
euroimmun
germani
inactiv
sar
cov
infect
vero
cell
use
antigen
purchas
medizinisch
labordiagnostika
ag
germani
three
serum
sampl
infecti
bronchiti
viru
ibv
infect
chicken
ibv
strain
also
test
experi
involv
use
inactiv
sar
cov
human
sar
inactiv
sera
perform
bsl
laboratori
sar
cov
ntermin
amino
acid
nucleocapsid
protein
express
purifi
describ
previous
use
anim
immun
well
antigen
antibodydetect
elisa
western
blot
assay
act
heterolog
antigen
optim
antigen
captur
elisa
four
balbc
mice
inject
subcutan
g
purifi
protein
emulsifi
equal
volum
adjuv
seppic
franc
three
time
interv
mice
receiv
final
booster
inject
g
antigen
l
pb
intraperiton
caviti
day
prior
hybridoma
fusion
mice
sacrif
spleen
cell
harvest
mice
myeloma
cell
logphas
growth
prior
fusion
spleen
cell
yokoyama
hybridoma
cultur
supernat
screen
use
elisa
ifa
western
blot
describ
previous
desir
clone
identifi
expand
cm
flask
one
week
later
hybridoma
suspens
harvest
cell
debri
pellet
via
centrifug
g
min
follow
collect
supernat
storag
c
fifti
microlit
hybridoma
supernat
incub
micropl
nunc
denmark
coat
purifi
nucleocapsid
protein
bound
antibodi
detect
dilut
horseradish
peroxidas
hrp
label
rabbit
antimous
immunoglobulin
dako
denmark
extens
wash
plate
incub
ophenylenediamin
dihydrochlorid
opd
sigma
usa
min
reaction
stop
addit
l
h
absorb
nm
read
use
tecan
micropl
reader
hybridoma
supernat
dilut
sampl
buffer
mix
thoroughli
vortex
follow
analysi
commerci
kit
euroimmuno
germani
sar
cov
infect
vero
cell
use
fluoresc
antigen
two
techniqu
use
confirm
reactiv
n
protein
accord
previou
descript
et
al
reactiv
mab
evalu
antigen
captur
elisa
purifi
employ
standard
antigen
twofold
serial
dilut
mab
detector
antibodi
hybridoma
supernat
produc
mab
serv
neg
control
isotyp
perform
use
mous
mab
isotyp
kit
amersham
bioscienc
england
guinea
pig
immun
g
purifi
protein
booster
inject
administ
interv
ten
day
later
anim
euthan
serum
prepar
sampl
evalu
antibodi
western
blot
subsequ
igg
extract
antiserum
use
protein
affin
chromatographi
sigma
usa
concentr
determin
use
bca
measur
kit
sigma
usa
reactiv
igg
n
protein
assess
antigen
captur
elisa
describ
flat
bottom
microtit
plate
nunc
demark
coat
ng
purifi
igg
l
carbon
buffer
mm
sodium
bicarbon
mm
sodium
carbon
per
well
incub
c
h
c
overnight
plate
wash
three
time
pbst
block
l
block
solut
nonfat
milk
pbst
incub
c
h
plate
rins
pbst
three
time
l
purifi
protein
pbst
contain
nonfat
milk
ad
plate
wash
three
time
pbst
l
mab
ad
well
plate
wash
l
rabbit
antihuman
immunoglobulin
hrpconjug
antibodi
ad
dilut
anoth
extens
wash
pbst
l
opd
ad
well
plate
incub
room
temperatur
min
absorb
read
nm
elisa
optim
monoclon
antibodi
purifi
igg
serial
dilut
twofold
use
detector
captur
antibodi
respect
new
assay
optim
condit
determin
compar
homolog
heterolog
reaction
achiev
highest
specif
signaltonois
ratio
assay
signalto
nois
ratio
calcul
divid
absorb
homolog
antigen
heterolog
antigen
purifi
ngl
serial
dilut
nonfat
milk
pbst
diluent
use
test
antigen
captur
elisa
format
describ
diluent
employ
blank
control
prior
test
inactiv
sar
cov
cultur
pfuml
treat
sampl
lysi
solut
triton
nonfat
milk
pb
incub
c
h
centrifug
g
min
supernat
assay
vero
cell
use
neg
control
detect
limit
standard
protein
sar
cov
determin
accord
cutoff
valu
calcul
formula
x
chicken
infecti
bronchiti
viru
ibv
one
anim
coronavirus
propag
spf
embryo
debri
remov
harvest
viru
supernat
centrifug
titer
viru
determin
eid
ml
ibv
treat
use
sampl
lysi
buffer
method
use
sar
cov
assay
way
twenti
five
microlit
purifi
concentr
ngl
respect
mix
guinea
pig
serum
serum
sar
convalesc
patient
addit
tcid
inactiv
sar
cov
incub
guinea
pig
serum
normal
guinea
pig
human
normal
sera
includ
neg
serum
control
content
subsequ
incub
c
h
follow
incub
c
h
sandwich
elisa
analysi
describ
percent
inhibit
antibodi
bind
calcul
follow
formula
inhibit
posit
serum
normal
serum
specif
block
confirm
percentag
inhibit
greater
detect
sar
cov
protein
human
infect
cell
mimick
use
cell
express
recombin
nucleocapsid
protein
accord
previou
report
et
al
pellet
resuspend
sampl
lysi
solut
incub
c
h
serial
dilut
nonfat
milk
pbst
test
noninfect
cell
use
neg
control
detect
limit
recombin
n
protein
cell
lysat
determin
accord
cutoff
valu
x
thirti
serum
sampl
obtain
healthi
individu
use
test
determin
cutoff
valu
new
captur
elisa
subsequ
serum
sampl
collect
patient
infect
sar
cov
sar
outbreak
singapor
shown
igmposit
use
inactiv
sar
covbas
ifa
serum
sampl
avail
sar
recoveri
patient
blood
donor
respect
test
antigen
captur
elisa
fusion
spleen
cell
immun
balbc
mice
sp
myeloma
cell
produc
sever
hybridoma
clone
secret
mab
protein
data
shown
posit
clone
determin
indirect
elisa
least
threefold
higher
absorb
background
posit
clone
show
great
variat
abil
secret
mab
hybridoma
cell
line
yield
highest
antibodi
titer
select
produc
monoclon
antibodi
analys
experi
incub
mab
fitcconjug
antibodi
subsequ
examin
fluoresc
microscopi
posit
cytoplasm
immunofluoresc
stain
authent
viru
antigen
infect
vero
cell
recombin
express
cell
shown
fig
ident
obtain
guinea
pig
monospecif
antibodi
fig
human
sar
patient
serum
fig
fluoresc
stain
observ
noninfect
vero
cell
cell
fig
e
fig
e
specif
reactiv
mab
purifi
protein
fig
ident
human
sar
posit
serum
fig
reaction
observ
nonantibodi
secret
hybridoma
test
fig
titrat
mab
elisa
western
blot
fusion
protein
base
ifa
sar
cov
infect
cellbas
ifa
respect
final
isotyp
repres
mab
determin
class
elisa
reactiv
purifi
shown
fig
increas
dilut
factor
mab
absorb
gradual
decreas
absorb
mab
dilut
nearli
equival
blank
control
thu
reactiv
dosedepend
standard
sandwich
elisa
igg
isol
purifi
pool
guinea
pig
sera
whose
titer
determin
western
blot
concentr
extract
igg
determin
gl
sdspage
analysi
show
two
band
appropri
kda
repres
heavi
light
chain
region
data
shown
expect
dosedepend
reactiv
purifi
igg
occur
fig
absorb
far
greater
obtain
concentr
nonimmun
guinea
pig
serum
absorb
decreas
dramat
igg
concentr
gwell
reactiv
ng
igg
equal
blank
igg
control
first
step
develop
elisa
mab
purifi
igg
dilut
coat
buffer
use
captur
antibodi
coat
microtit
plate
respect
howev
igg
bind
hydrophob
hydrophil
microtit
plate
effici
mab
therefor
elisa
plate
coat
purifi
igg
incub
c
overnight
c
h
follow
experi
hrpconjug
antibodi
use
recommend
concentr
test
dilut
captur
antibodi
gwell
dilut
mab
determin
optim
work
condit
base
signaltonois
ratio
tabl
antigen
captur
elisa
standard
use
optim
condit
absorb
valu
normal
vero
cell
respect
therefor
cutoff
valu
detect
virus
cell
cultur
determin
x
accord
cutoff
threshold
dilut
protein
dilut
sar
cov
suspens
consid
posit
fig
deduc
littl
pg
purifi
protein
tcid
sar
cov
could
detect
cell
cellsml
infect
rate
recombin
baculoviru
h
postinfect
base
fluoresc
assay
use
mab
primari
antibodi
l
aliquot
dilut
cell
lysat
supernat
subject
elisa
absorb
valu
obtain
dilut
accord
calcul
cutoff
valu
test
abl
detect
dilut
infect
cell
cellsml
fig
thu
infect
cell
could
detect
elisa
accord
cutoff
valu
base
detect
sampl
healthi
individu
sar
cov
n
protein
could
detect
ifa
igmposit
sera
none
nine
sampl
sar
recoveri
patient
use
new
elisa
fals
posit
result
produc
sera
healthi
blood
donor
recognit
site
mab
protein
block
guinea
pig
serum
human
sar
posit
serum
lead
lower
absorb
fig
sar
cov
could
detect
incub
serum
human
guinea
pig
normal
serum
could
inhibit
bind
mab
nativ
viral
nucleocap
test
dilut
igg
mab
use
standard
captur
elisa
number
repres
signaltonois
ratio
sampl
measur
differ
combin
captur
detector
antibodi
antigen
captur
elisa
fig
inhibit
effect
guinea
pig
serum
human
sar
posit
serum
recognit
nucleocapsid
antigen
detector
antibodi
group
g
group
g
group
tcid
sar
cov
differ
concentr
protein
sar
cov
incub
guinea
pig
serum
human
sar
posit
serum
long
bar
guinea
pig
human
normal
serum
short
bar
respect
content
subject
captur
elisa
sid
antigen
longer
bar
calcul
inhibit
rate
shorter
bar
addit
crossreact
observ
ibv
test
result
demonstr
antigen
captur
elisa
highli
specif
detect
nucleocapsid
antigen
sar
cov
sar
cov
etiolog
agent
caus
sever
acut
respiratori
syndrom
newli
emerg
diseas
global
need
develop
sensit
specif
immunoassay
detect
sar
cov
previou
work
major
immunodomain
n
protein
identifi
western
blot
assay
develop
detect
antibodi
sar
cov
therefor
reason
assum
mab
protein
improv
test
specif
paper
describ
product
monoclon
antibodi
protein
well
develop
antigen
captur
elisa
offer
safe
costeffect
tool
detect
sar
coronaviru
test
mab
react
authent
nucleocapsid
sar
cov
indic
potenti
mab
detect
sar
cov
immunoassay
moreov
mab
dilut
detect
cellbas
ifa
wherea
mab
dilut
could
detect
sar
cov
infect
vero
cellsbas
ifa
partial
explain
fact
nucleocapsid
gene
fuse
truncat
spike
gene
place
transcript
control
strong
polyhedrin
promot
autographa
californica
nuclear
polyhedrosi
viru
acnpv
recombin
baculoviru
lead
abund
infect
cell
recognit
authent
nucleocapsid
antigen
indic
mab
produc
work
use
develop
immunoassay
instanc
ifa
direct
detect
sar
cov
nasopharyng
aspir
obtain
patient
diagnos
probabl
suspect
case
clinic
criteria
compar
mab
igg
display
stronger
bind
microtit
plate
therefor
use
captur
antibodi
mab
detector
antibodi
antigen
captur
elisa
detect
limit
test
pg
standard
protein
tcid
sar
cov
sensit
consist
previou
descript
sensit
antigen
captur
elisa
attempt
improv
sensit
assay
mab
immunogen
sc
fragment
spike
protein
produc
experi
use
detector
antibodi
detect
spike
protein
infect
cell
lysat
inactiv
sar
cov
howev
method
improv
sensit
specif
test
specif
bind
recombin
nativ
nucleocapsid
mab
uniformli
inhibit
guinea
pig
monospecif
antiserum
human
sar
posit
serum
human
guinea
pig
normal
sera
due
lack
coronaviru
infect
human
sampl
ibv
use
assess
specif
mab
coronavirus
experi
ibv
could
recogn
mab
indic
mab
specif
observ
suggest
mabbas
assay
specif
detect
sar
cov
infect
moreov
n
protein
consist
detect
limit
igmposit
sampl
eight
iggposit
sera
convalesc
patient
indic
potenti
earli
detect
sar
cov
infect
although
need
clinic
trial
consist
new
find
di
et
al
theoret
antigen
releas
infect
cell
virus
appear
host
blood
system
follow
presenc
rel
specif
antibodi
addit
due
abund
express
n
protein
compar
protein
viral
replic
infect
tissu
host
immun
system
expos
larger
load
n
antigen
therefor
antigen
captur
elisa
base
mab
n
protein
might
provid
sensit
method
earli
detect
sar
cov
infect
